Neonatal non-immune hydrops due to large placental chorioangioma -a treatable cause of hydrops
Abstract
The term non-immunologic hydrops fetalis (NIHF) defines an edematous fetus with fluid collections in some usually two or all serous cavities that does not have erythroblastosis fetalis from isoimmunization. Ballantyne described the first case of non-immune hydrops. In 1943 Dr Edith Potter published the first description of NIHF. Hydrops Fetalis is considered as a prenatal form of cardiac failure. Hydrops may present as a stiffness of one limb due to edema (present case) to severe generalized anasarca with bilateral pleural effusion. Usually non-immune hydrops associated with severe morbidity and mortality. NIHF not only caused by fatal fetal causes like Chromosomal, alpha thalassemia, infections and cardiac causes but also caused by placental causes like twin to twin transfusion syndrome and placental tumours like placental chorioangioma, among these last entity usually have good prognosis if we managed properly in utero or at the time of delivery and early postnatal days. Some cases of non-immune hydrops amenable to treatment and will have better prognosis like chylothorax, CCAM, Supra Ventricular Tachycardia (SVT), bladder obstruction and hydrothorax.
Downloads
References
2. Faes T, Pecceu A, Van Calenbergh S, Moerman P. Chorangiocarcinoma of the placenta: a case report and clinical review. Placenta. 2012;33(8):658-661. doi: 10. 1016/j.placenta.2012.04.012. Epub 2012 May 25.
3. Sohan K, Carroll SG, De La Fuente S, Soothill P, Kyle P. Analysis of outcome in hydrops fetalis in relation to gestational age at diagnosis, cause and treatment. Acta Obstet Gynecol Scand. 2001;80(8):726-730. doi: https://doi.org/10.1034/j.1600-0412.2001. 080 008726.x.
4. Bianchi DW, Crombleholme TM, D’Alton ME. Fetology: Diagnosis and management of the fetal patient. McGraw-Hill; 2000. p. 959.
5. Holzgreve W, Holzgreve B, Curry CJR. Non-immune hydrops fetalis-diagnosis and management. Semin Perinatol. 1985;9(2):52–67.
6. Gough JD, Keeling JW, Castle B, Illiff PJ. The obstetric management of non-immune Hydrops. Br J Obstet Gynaecol. 1986;93(3):226-234.
7. Heinonen S, Ryynänen M, Kirkinen P. Etiology and outcome of second trimester non-immunologic fetal hydrops. Acta Obstet Gynecol Scand. 2000;79(1):15-18. doi: https://doi.org/10.1034/j.1600-0412.2000. 0790 01015.x.
8. Kesrouani AK, Safi J, El Hajj MA. Rapid evolution of placental chorioangioma: natural progression and outcome. J Ultrasound Med. 2013;32(3):545-547. doi: 10. 7863/jum.2013.32.3.545.
9. Chen CP, Chern SR, Wang TY, Huang ZD, Huang MC, Chuang CY. Pregnancy with concomitant chorangioma and placental vascular malformation with mesenchymal hyperplasia. Hum Reprod. 1997;12(11): 2553-2556. doi: 10.1093/humrep/12.11.2553.
10. Hosseinzadeh P, Shamshirsaz AA, Javadian P, et al. PrenatalTherapy of Large Placental Chorioangiomas: Case Report andReview of the Literature. Am J Perinatol. 2015;5(2): e196–e202. doi: 10.1055/s-0035-1558829.
11. García-Díaz L, Carreto P, Costa-Pereira S, Antiñolo G. Prenatal management and perinatal outcome in giant placental chorioangioma complicated with hydrops fetalis, fetal anemia and maternal mirror syndrome. BMC Preg Childbirth. 2012;12(1):72. doi: 10.1186/ 1471- 2393-12-72.
12. Hadi HA, Finley J, Strickland D. Placental Chorioangioma, Prenatal Diagnosis and Clinical Significance. Am J Perinatol. 1993;10(02):146-149. doi: 10. 1055/s-2007-994648.
13. Bauer CR, Fojaco RM, Bancalari E, Fernandez-Rocha L. Microangiopathic hemolytic anemia and thrombocytopenia in a neonate associated with a large placental chorioangioma. Pediatr. 1978;62(4):574-577.
14. Vaisbuch E, Romero R, Kusanovic JP, Erez O, Mazaki-Tovi S, et al. Three-dimensional sonography of placental mesenchymal dysplasia and its differential diagnosis. J Ultrasound Med. 2009;28(3):359-368. doi: 10.7863/jum.2009.28.3.359.
15. Society for Maternal-Fetal Medicine (SMFM), Norton ME1, Chauhan SP2, Dashe JS. Society for maternal-fetal medicine (SMFM) clinical guideline #7: nonimmune hydrops fetalis. Am J Obstet Gynecol. 2015; 212(2):127-139. doi: 10.1016/j.ajog.2014.12.018. Epub 2014 Dec 31.
16.Abdalla N, Bachanek M, Trojanowski S, Cendrowski K, Sawicki W. Placental tumor (chorioangioma) as a cause of polyhydramnios: a case report. Int J Womens Health. 2014;6:955-959. doi: 10. 2147/IJWH.S72178. eCollection 2014.
17. Imdad A, Sheikh L, Malik A. A large chorio-angioma causing intrauterine foetal demise. J Pak Med Assoc. 2009;59(8):580-581.
18. Kodandapani S, Shreshta A, Ramkumar V, Rao L. Chorioangioma of placenta: a rare placental cause for adverse fetal outcome. Case Rep Obstet Gynecol. 2012; 2012: 913878. doi: 10.1155/2012/913878.
19. Kataria N, Singh A, Bedi PK. Giant placental chorangioma: a rare case report. J Clinic Diagnos Res: JCDR. 2016; 10(4): ED03-ED04. doi: 10.7860/JCDR/ 2016 / 17222.7540.
20. Hosseinzadeh P, Shamshirsaz AA, Javadian P, Espinoza J, Gandhi M, Ruano R, Cass DL, et al. Prenatal Therapy of Large Placental Chorioangiomas: Case Report and Review of the Literature. Am J Perinatol. 2015; 5(2): e196–e202. doi: 10.1055/s-0035-1558829.
21. Braun T, Brauer M, Fuchs I, Czernik C, Dudenhausen JW, Henrich W, et al. Mirror syndrome: a systematic review of fetal associated conditions, maternal presentation and perinatal outcome. Fetal Diagn Ther. 2010; 27(4): 191-203. doi: 10.1159/ 000 305096. Epub 2010 Mar 27.
Copyright (c) 2019 Author (s). Published by Siddharth Health Research and Social Welfare Society
This work is licensed under a Creative Commons Attribution 4.0 International License.
OAI - Open Archives Initiative
